These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. HLA-Cw8 primarily associated with hypersensitivity to nevirapine. Gatanaga H; Yazaki H; Tanuma J; Honda M; Genka I; Teruya K; Tachikawa N; Kikuchi Y; Oka S AIDS; 2007 Jan; 21(2):264-5. PubMed ID: 17197830 [No Abstract] [Full Text] [Related]
7. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients. Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551 [TBL] [Abstract][Full Text] [Related]
8. Stevens-Johnson syndrome in an HIV-infected patient. Blitz M; Spivack E; Kerpel SM; Freedman PD AIDS Read; 1999; 9(3):184-5, 190. PubMed ID: 12728904 [TBL] [Abstract][Full Text] [Related]
10. Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity. Raffi F; Lewden C; Chêne G AIDS; 2008 Jan; 22(3):435-6. PubMed ID: 18195573 [No Abstract] [Full Text] [Related]
12. Side effects. Severe nevirapine rash found more likely in women than men. TreatmentUpdate; 2001; 12(8):7. PubMed ID: 12132442 [No Abstract] [Full Text] [Related]
13. Nevirapine-associated rash in a Jamaican child with HIV/AIDS. Steel-Duncan JC; Pierre R; Gabay L; Christie CD West Indian Med J; 2004 Oct; 53(5):356-8. PubMed ID: 15675504 [TBL] [Abstract][Full Text] [Related]
14. Severe hepatic failure related to nevirapine treatment. Cattelan AM; Erne E; Salatino A; Trevenzoli M; Carretta G; Meneghetti F; Cadrobbi P Clin Infect Dis; 1999 Aug; 29(2):455-6. PubMed ID: 10476768 [No Abstract] [Full Text] [Related]
15. HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients. Littera R; Carcassi C; Masala A; Piano P; Serra P; Ortu F; Corso N; Casula B; La Nasa G; Contu L; Manconi PE AIDS; 2006 Aug; 20(12):1621-6. PubMed ID: 16868443 [TBL] [Abstract][Full Text] [Related]
16. Toxic epidermal necrolysis induced by nevirapine therapy: description of two cases and review of the literature. Cattelan AM; Trevenzoli M; Sasset L; Sgarabotto D; Lanzafame M; Meneghetti F J Infect; 2001 Nov; 43(4):246-9. PubMed ID: 11869062 [TBL] [Abstract][Full Text] [Related]